These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19540817)

  • 1. Review on early technology assessments of nanotechnologies in oncology.
    Retèl VP; Hummel MJ; van Harten WH
    Mol Oncol; 2009 Dec; 3(5-6):394-401. PubMed ID: 19540817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early phase Technology Assessment of nanotechnology in oncology.
    Retèl VP; Hummel MJ; van Harten WH
    Tumori; 2008; 94(2):284-90. PubMed ID: 18564618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
    Retèl VP; Bueno-de-Mesquita JM; Hummel MJ; van de Vijver MJ; Douma KF; Karsenberg K; van Dam FS; van Krimpen C; Bellot FE; Roumen RM; Linn SC; van Harten WH
    Int J Technol Assess Health Care; 2009 Jan; 25(1):73-83. PubMed ID: 19126254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Nanotechnology in the Management of Cancer: Miniature Technology, Great Potential.
    Jawad Z; Xie F; Jiao LR
    JAMA Surg; 2015 Dec; 150(12):1184-5. PubMed ID: 26444693
    [No Abstract]   [Full Text] [Related]  

  • 7. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects and applications of nanobiotechnology: a medical perspective.
    Fakruddin M; Hossain Z; Afroz H
    J Nanobiotechnology; 2012 Jul; 10():31. PubMed ID: 22817658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnologies in cancer treatment and diagnosis.
    Morris SA; Farrell D; Grodzinski P
    J Natl Compr Canc Netw; 2014 Dec; 12(12):1727-33. PubMed ID: 25505214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodology of constructive technology assessment in health care.
    Douma KF; Karsenberg K; Hummel MJ; Bueno-de-Mesquita JM; van Harten WH
    Int J Technol Assess Health Care; 2007; 23(2):162-8. PubMed ID: 17493301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
    Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J
    Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legal aspects of the risks raised by nanotechnologies in the field of medicine.
    Poirot-Mazères I
    J Int Bioethique; 2011; 22(1):99-118, 212. PubMed ID: 21850972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual health services.
    Schnell-Inderst P; Hunger T; Hintringer K; Schwarzer R; Seifert-Klauss VR; Gothe H; Wasem J; Siebert U
    GMS Health Technol Assess; 2011; 7():Doc05. PubMed ID: 21966301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nanopsychiatry. The potential role of nanotechnologies in the future of psychiatry. A systematic review].
    Fond G; Miot S
    Encephale; 2013 Sep; 39(4):252-7. PubMed ID: 23545476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research advancement and prospects of nanotechnology in early diagnosis and treatment of cancer].
    Hu DH; Gong P; Ma YF; Cai LT
    Ai Zheng; 2009 Sep; 28(9):1000-3. PubMed ID: 19728922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.